Abstract
A paradigm shift is occurring in the way nephrologists evaluate patients with progressive chronic kidney disease for initiation of maintenance renal replacement therapy. Serum creatinine and serum creatinine-based equations used to calculate an estimated glomerular filtration rate (eGFR) are not accurate approximations of renal function at low levels. Further complicating matters is a trend toward early initiation of dialysis, once considered beneficial since patients had better outcomes if they started dialysis before the onset of protein malnutrition. But recent data, including results of a large randomized controlled trial, suggest no benefit and possibly increased risk of death with early initiation of dialysis. This review will examine the data and where the field stands in deciding when to initiate dialysis.
Keywords: Dialysis, early and late initiation, glomerular filtration rate.
Cardiovascular & Hematological Disorders-Drug Targets
Title:Initiation of Dialysis: A Mini-Review of a Changing Paradigm
Volume: 14 Issue: 3
Author(s): George Bayliss
Affiliation:
Keywords: Dialysis, early and late initiation, glomerular filtration rate.
Abstract: A paradigm shift is occurring in the way nephrologists evaluate patients with progressive chronic kidney disease for initiation of maintenance renal replacement therapy. Serum creatinine and serum creatinine-based equations used to calculate an estimated glomerular filtration rate (eGFR) are not accurate approximations of renal function at low levels. Further complicating matters is a trend toward early initiation of dialysis, once considered beneficial since patients had better outcomes if they started dialysis before the onset of protein malnutrition. But recent data, including results of a large randomized controlled trial, suggest no benefit and possibly increased risk of death with early initiation of dialysis. This review will examine the data and where the field stands in deciding when to initiate dialysis.
Export Options
About this article
Cite this article as:
Bayliss George, Initiation of Dialysis: A Mini-Review of a Changing Paradigm, Cardiovascular & Hematological Disorders-Drug Targets 2014; 14 (3) . https://dx.doi.org/10.2174/1871529X14666140401111115
DOI https://dx.doi.org/10.2174/1871529X14666140401111115 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Queries Addressed in Patients with Systemic Autoimmune Diseases. Can Cardiovascular Magnetic Resonance Give the Final Solution?
Inflammation & Allergy - Drug Targets (Discontinued) The Role of Colchicine in the Treatment of Autoinflammatory Diseases
Current Pharmaceutical Design Chemotherapeutic Options for Colorectal Cancer Patients with Cardiovascular Diseases.
Reviews on Recent Clinical Trials Antiarrhythmic Therapy on Prevention of Postoperative Atrial Fibrillation in Patients After Heart Surgery
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report
Infectious Disorders - Drug Targets Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
Current Stem Cell Research & Therapy Monoclonal Antibodies in the Treatment of Systemic Lupus Erythematosus
Current Drug Targets Bactericidal Activity of a Cationic Peptide on Neisseria meningitidis
Infectious Disorders - Drug Targets Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus
Current Cardiology Reviews In Vivo Osteoarthritis Target Validation Utilizing Genetically-Modified Mice
Current Drug Targets Colchicine in Neurosurgery
Current Pharmaceutical Design Glucocorticoids and the Cardiovascular System: State of the Art
Current Pharmaceutical Design FDG-PET in Tuberculosis
Current Molecular Imaging (Discontinued) Pharmacological Interventions for the Prevention and Treatment of Kidney Injury Induced by Radiotherapy: Molecular Mechanisms and Clinical Perspectives
Current Molecular Pharmacology Deep Inspiration Breath-hold (DIBH) Technique to Reduce Cardiac Radiation Dose in the Management of Breast Cancer
Current Cancer Therapy Reviews Radioprotective Effects of Plants from the Lamiaceae Family
Anti-Cancer Agents in Medicinal Chemistry Dietary Modulation of Thymic Enzymes
Endocrine, Metabolic & Immune Disorders - Drug Targets What Does a Pediatrician Need to Know About Chronic Diarrhea?
Current Pediatric Reviews Enhancement of Immunoprotective Effect of CpG-ODN by Formulation with Polyphosphazenes Against E. coli Septicemia in Neonatal Chickens
Current Drug Delivery Vascular Toxicity of Chemotherapeutic Agents
Current Vascular Pharmacology